Microglial ‘fingers’ probe dense brain structures in health and disease
New UBC research expands our understanding of the brain’s immune cells.
Alternative income assistance payment schedules could reduce drug use and related harm
Study led by Lindsay Richardson examined whether varying the timing and frequency of income assistance payments can mitigate drug-related harms.
Steroids can reduce lung cancer risk in COPD patients
New UBC study co-authored by Don Sin evaluated 10 years’ worth of medical and pharmacy data.
CREST.BD network recognized by CIHR for transformation in patient engagement
CREST.BD and its leader, Erin Michalak, received a Gold Leaf Prize for excellence in translational health research.
Wearable brain devices marketed to consumers raise ethical questions
Neuroethicist Judy Illes recommends caution with wearable brain devices
Award supports research into broad-spectrum childhood cancer treatments
Mads Daugaard is given carte blanche to discover solid tumour treatments for children.
Mining 25 years of data uncovers a new predictor of age of onset for Huntington disease
UBC researchers have uncovered a genetic variant that significantly influences age of onset in patients.
A new way of diagnosing and treating disease — without cutting skin
UBC researchers develop new laser microscope that could be ‘revolutionary’ for treatment of diseases such as skin cancer.
Kids with harder to manage diabetes improve the most from insulin pumps
New research led by Brenden Hursh suggests clinicians may need to rethink which children are offered this treatment.
Huntington drug successfully lowers levels of disease-causing protein
An international clinical trial has found that a new drug for Huntington disease is safe and lowers levels of disease-causing protein.